FTC sues big pharmacy benefit managers more than insulin selling prices The company introduced motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list price of lifestyle-conserving insulin prescription drugs. The place are the many nurses? Hospitals, advocates disagree on crisis https://rowanqnidz.boyblogguide.com/29953927/everything-about-healthcare-news